Tandem Diabetes Care Stock Market Value
| TNDM Stock | USD 30.63 0.59 1.89% |
| Symbol | Tandem |
Tandem Diabetes Care Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share (1.94) | Revenue Per Share 13.082 | Quarterly Revenue Growth 0.314 | Return On Assets (0.1) |
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tandem Diabetes 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tandem Diabetes' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tandem Diabetes.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Tandem Diabetes on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Tandem Diabetes Care or generate 0.0% return on investment in Tandem Diabetes over 30 days. Tandem Diabetes is related to or competes with DexCom, Inspire Medical, Penumbra, Insulet, Abbott Laboratories, Align Technology, and Stryker. Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people ... More
Tandem Diabetes Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tandem Diabetes' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tandem Diabetes Care upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 12.63 | |||
| Value At Risk | (4.60) | |||
| Potential Upside | 4.24 |
Tandem Diabetes Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tandem Diabetes' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tandem Diabetes' standard deviation. In reality, there are many statistical measures that can use Tandem Diabetes historical prices to predict the future Tandem Diabetes' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.43) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tandem Diabetes' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Tandem Diabetes Care Backtested Returns
Tandem Diabetes Care owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Tandem Diabetes Care exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tandem Diabetes' Risk Adjusted Performance of (0.12), variance of 9.63, and Coefficient Of Variation of (605.36) to confirm the risk estimate we provide. The entity has a beta of 1.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tandem Diabetes will likely underperform. At this point, Tandem Diabetes Care has a negative expected return of -0.44%. Please make sure to validate Tandem Diabetes' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Tandem Diabetes Care performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.23 |
Weak reverse predictability
Tandem Diabetes Care has weak reverse predictability. Overlapping area represents the amount of predictability between Tandem Diabetes time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tandem Diabetes Care price movement. The serial correlation of -0.23 indicates that over 23.0% of current Tandem Diabetes price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 0.96 |
Tandem Diabetes Care lagged returns against current returns
Autocorrelation, which is Tandem Diabetes stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tandem Diabetes' stock expected returns. We can calculate the autocorrelation of Tandem Diabetes returns to help us make a trade decision. For example, suppose you find that Tandem Diabetes has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tandem Diabetes regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tandem Diabetes stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tandem Diabetes stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tandem Diabetes stock over time.
Current vs Lagged Prices |
| Timeline |
Tandem Diabetes Lagged Returns
When evaluating Tandem Diabetes' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tandem Diabetes stock have on its future price. Tandem Diabetes autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tandem Diabetes autocorrelation shows the relationship between Tandem Diabetes stock current value and its past values and can show if there is a momentum factor associated with investing in Tandem Diabetes Care.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Tandem Diabetes Correlation, Tandem Diabetes Volatility and Tandem Diabetes Alpha and Beta module to complement your research on Tandem Diabetes. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Tandem Diabetes technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.